Biogen Beats

Biogen (BIIB) reported 1st Quarter March 2026 earnings of $3.57 per share on revenue of $2.5 billion. The consensus earnings estimate was $2.95 per share on revenue of $2.3 billion. The Earnings Whisper number was $3.24 per share. Revenue grew 1.9% on a year-over-year basis.

Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.